Ting, W. (2023). A novel intergenic region (chr2: 30,193,816)-ALK fusion shows sensitivity to Alectinib in lung adenocarcinoma. Springer.
Chicago Style CitationTing, Wang. A Novel Intergenic Region (chr2: 30,193,816)-ALK Fusion Shows Sensitivity to Alectinib in Lung Adenocarcinoma. Springer, 2023.
MLA CitationTing, Wang. A Novel Intergenic Region (chr2: 30,193,816)-ALK Fusion Shows Sensitivity to Alectinib in Lung Adenocarcinoma. Springer, 2023.
Warning: These citations may not always be 100% accurate.